Table 1.

Demographic and structural data for 3 groups: ageing donors that had not suffered a fracture (Controls) and ageing fracture patients, both untreated (Fx-Untreated) and bisphosphonate-treated (Fx-BisTreated).

Donor group	Donor number	Sex	Age (years)	BV/TV	Treatment (years)
Control	1	M	84	0.30
	2	M	73	0.34
	3	F	73	0.38
	4	F	73	0.27
	5	F	82	0.34
	6	F	82	0.33
	7	F	72	0.36
	8	F	72	0.36
	9	M	57	0.33
	10	M	73	0.33
Fx-Untreated	1	F	82	0.24
	2	F	76	0.28
	3	F	82	0.24
	4	F	81	0.25
	5	F	75	0.25
	6	F	74	0.22
	7	M	94	0.24
	8	M	79	0.26
	9	F	90	0.31
	10	M	78	0.26
Fx-BisTreated	1	F	88	0.29	9
	2	F	61	0.24	6
	3	F	79	0.26	5
	4	F	82	0.26	5
	5	F	84	0.37	5
	6	F	75	0.25	3
	7	F	82	0.42	2
	8	M	80	0.25	1
	9	F	68	0.23	1
	10	F	79	0.30	1